Astellas Pharma Inc.
Astellas Pharma Inc. (ALPMF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALPMF · as of Jun 8, 2026
Key Statistics
Explore Astellas Pharma Inc. Data
alpmf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
alpmf competitorsALPMF
BMXXY
CHJTF
CSPCY
FMCQF
GIKLYStock Performance
Full HistoryAbout Astellas Pharma Inc.
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, …
what is astellas pharma inc. · alpmf stock overview · astellas pharma inc. company profile · who is astellas pharma inc. ceo · alpmf OTC · astellas pharma inc. headquarters · astellas pharma inc. business segments
About Stock Overview & Key Data
Astellas Pharma Inc. (ALPMF) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Apr 26, 2010. As of the latest trading session, ALPMF stock price is $14.70, with a market capitalization of $26.3B. The stock has returned +45.54% over the past 12 months and +11.62% year-to-date.
In fiscal year 2026, Astellas Pharma Inc. reported revenue of $2.15T. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Astellas Pharma Inc. (ALPMF) stock price is $14.70. The stock is traded on OTC under the ticker symbol ALPMF. The 52-week range is $9.34 – $17.85.